Evidence map›Paper›PMID 31315063›Full record

ArticleFree radical biology & medicine2019

Age-dependent dysregulation of redox genes may contribute to fibrotic pulmonary disease susceptibility.

Evan A Elko, J Matthew Mahoney, Pamela Vacek, Albert van der Vliet, Vikas Anathy, Jos L J L van der Velden, Yvonne M W Janssen-Heininger, David J Seward

Open access · hybridAbstract read
In one paragraph

Article in Free radical biology & medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Dysregulation of the glutaredoxin/American journal of physiology. Cell physiology · 2020
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Evan A ElkoDepartment of Pathology and Laboratory Medicine, The University of Vermont, Burlington, VT, 05405, USA.
J Matthew MahoneyDepartment of Neurological Sciences, The University of Vermont, Burlington, VT, 05405, USA.
Pamela VacekMedical Biostatistics, The University of Vermont, Burlington, VT, 05405, USA.
Albert van der VlietDepartment of Pathology and Laboratory Medicine, The University of Vermont, Burlington, VT, 05405, USA.
Vikas AnathyDepartment of Pathology and Laboratory Medicine, The University of Vermont, Burlington, VT, 05405, USA.
Jos L J L van der VeldenDepartment of Pathology and Laboratory Medicine, The University of Vermont, Burlington, VT, 05405, USA.
Yvonne M W Janssen-HeiningerDepartment of Pathology and Laboratory Medicine, The University of Vermont, Burlington, VT, 05405, USA.
David J SewardDepartment of Pathology and Laboratory Medicine, The University of Vermont, Burlington, VT, 05405, USA. Electronic address: David.Seward@uvm.edu.
University of Vermont · USUniversity of Vermont Medical Center · US

Funding

S-glutathionylation chemistry in fibrotic lung remodelingR35HL135828 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 2017 to 2023
$6.5M
Multidisciplinary Training in Lung BiologyT32HL076122 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI IRVIN, CHARLES G, POYNTER, MATTHEW E · 2004 to 2023
$6.1M
Dual Oxidase in Airway Epithelial Repair and RemodelingR01HL085646 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 2008 to 2020
$4.7M
DUOX1 and Mitochondria in Obese AsthmaR01HL138708 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 2017 to 2020
$2.1M
S-glutathionylation chemistry, glycolysis and obese allergic asthmaR01HL137268 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI DIXON, ANNE E, VAN DER VLIET, ALBERT · 2017 to 2020
$2.1M
GSTP1-induced S-glutathionylation in lung cancerR01CA219156 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VAN DER VELDEN, ADRIANUS (JOS)L.J. · 2017 to 2021
$1.8M
DUOX1 Silencing in Age-Related COPDR21AG055325 · NIA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 2017 to 2018
$429k
NCI NIH HHS R01 CA219156NHLBI NIH HHS R01 HL085646NHLBI NIH HHS R01 HL137268NHLBI NIH HHS R01 HL138708NHLBI NIH HHS R35 HL135828NHLBI NIH HHS T32 HL076122NIA NIH HHS R21 AG055325
6 · The paper itself

Abstract

Aging is associated with enhanced oxidative stress and increased susceptibility to numerous diseases. This relationship is particularly striking with respect to the incidence of fibrotic lung disease. To identify potential mechanisms underlying the association between aging and susceptibility to fibrotic lung disease we analyzed transcriptome data from 342 disease-free human lung samples as a function of donor age. Our analysis reveals that aging in lung is accompanied by modest yet progressive changes in genes modulating redox homeostasis, the TGF-beta 1 signaling axis, and the extracellular matrix (ECM), pointing to an aging lung functional network (ALFN). Further, the transcriptional changes we document are tissue-specific, with age-dependent gene expression patterns differing across organ systems. Our findings suggest that the age-associated increased incidence of fibrotic pulmonary disease occurs in the context of tissue-specific, age-dependent transcriptional changes. Understanding the relationship between age-associated gene expression and susceptibility to fibrotic pulmonary disease may allow for more accurate risk stratification and effective therapeutic interventions within this challenging clinical space.

Indexed as

AdultAgedAgingDisease SusceptibilityExtracellular MatrixFemaleGene Expression RegulationHomeostasisHumansLung DiseasesMaleMiddle AgedOrgan SpecificityOxidation-ReductionPulmonary FibrosisRisk AssessmentAgingAging lung function networkExtracellular matrixLungOxidative stressOxidoreductasePulmonary fibrosisTransforming growth factor beta

Identifiers

PMID31315063
PMCPMC6820706
OpenAlexW2961056134

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.